Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Marmosets as the Canary in the Coal Mine for Zika

By Texas Biomedical Research Institute | May 2, 2018

New research shows small, New World monkeys called marmosets may be an important animal model for emerging viruses with the potential for harmful effects on fetuses. Establishing animal models for emerging diseases, like Zika, is necessary for the development of vaccines, therapies and diagnostics. Results of a study published in the journal Scientific Reports showed pregnant marmosets inoculated with the Zika virmarmosetus at a specific point during the first half of their pregnancy spontaneously aborted the fetuses at almost exactly the same time – about two weeks after the infection. In addition, histology on the fetuses showed neurological abnormalities.

“There is strong interest in the scientific community in developing animal models to understand Zika virus with the goal of developing vaccines and therapies,” said lead author Suzette Tardif, Ph.D., a Scientist at Texas Biomedical Research Institute and Associate Director of Research at the Southwest National Primate Research Center. “We believe marmosets may be an especially relevant model for effects on infection in pregnancy.”

While a number of different animals are being studied as possible models for investigations of the Zika virus, including macaques and baboons, this is one of several studies that showed marmosets may be especially sensitive to the infection.

“It’s early days, but the results are encouraging,” Tardif added.

Collaborators in the study included virologists, microbiologists, primatologists and OB/GYNs from Texas Biomed, the University of California at San Francisco, Baylor College of Medicine in Houston, and University of Illinois at Chicago.

After the initial outbreak of Zika in Brazil that caused a large number of babies to be born with severe brain abnormalities, scientists who capture marmosets in the wild found they had antibodies to Zika, indicating the monkeys do get infected with the mosquito-borne illness. A study published by Texas Biomed and UCSF scientists in 2017 found male marmosets mimic human disease when infected with the Zika virus, with the infection found to linger in saliva and semen.

“We have a theory that the placenta may be a reservoir for the Zika virus which would explain why there’s so much of it because we find a huge number of infected cells there,” said Jean Patterson, Ph.D., Texas Biomed Scientist in the Department of Virology & Immunology and senior author of the study.

With her research partners, Patterson is proposing further studies on the impact of West Nile and cytomegalovirus (CMV) infections in pregnant marmosets. The idea is that these animals could serve as an effective model for pinpointing whether emerging viruses cause fetal development problems during pregnancy.

The Southwest National Primate Research Center at Texas Biomed houses a colony of 300 marmosets. This study was funded by the generosity of many donors and the Southwest National Primate Research Center P51 National Institutes of Health grant #P51 OD011133.

SOURCE: Texas Biomedical Research Institute


Filed Under: Drug Discovery

 

Related Articles Read More >

Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE